These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 32550907)

  • 1. Herb-sourced emodin inhibits angiogenesis of breast cancer by targeting VEGFA transcription.
    Zou G; Zhang X; Wang L; Li X; Xie T; Zhao J; Yan J; Wang L; Ye H; Jiao S; Xiang R; Shi Y
    Theranostics; 2020; 10(15):6839-6853. PubMed ID: 32550907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An isoflavone derivative potently inhibits the angiogenesis and progression of triple-negative breast cancer by targeting the MTA2/SerRS/VEGFA pathway.
    Zhang X; Zou G; Li X; Wang L; Xie T; Zhao J; Wang L; Jiao S; Xiang R; Ye H; Shi Y
    Cancer Biol Med; 2020 Aug; 17(3):693-706. PubMed ID: 32944400
    [No Abstract]   [Full Text] [Related]  

  • 3. Emodin combined with 5-aminolevulinic acid photodynamic therapy inhibits condyloma acuminate angiogenesis by targeting SerRS.
    Lu H; Peng Z; Luo Y; Zheng Z; Li C; Wang Q; Han C; Wang Y; Liang L; Zeng K; Chen Y
    J Cell Mol Med; 2024 Oct; 28(19):e70122. PubMed ID: 39351642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blocking the ATR-SerRS-VEGFA pathway targets angiogenesis for UV-induced cutaneous squamous cell carcinoma.
    Lu H; Peng Z; Zheng Z; Li C; Wang Y; Liang L; Chen Y; Zeng K
    Mol Carcinog; 2024 Jun; 63(6):1160-1173. PubMed ID: 38695641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of seryl-tRNA synthetase by ATM/ATR is essential for hypoxia-induced angiogenesis.
    Shi Y; Liu Z; Zhang Q; Vallee I; Mo Z; Kishi S; Yang XL
    PLoS Biol; 2020 Dec; 18(12):e3000991. PubMed ID: 33351793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Competitive binding between Seryl-tRNA synthetase/YY1 complex and NFKB1 at the distal segment results in differential regulation of human vegfa promoter activity during angiogenesis.
    Fu CY; Wang PC; Tsai HJ
    Nucleic Acids Res; 2017 Mar; 45(5):2423-2437. PubMed ID: 27913726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emodin Inhibits Breast Cancer Growth by Blocking the Tumor-Promoting Feedforward Loop between Cancer Cells and Macrophages.
    Iwanowycz S; Wang J; Hodge J; Wang Y; Yu F; Fan D
    Mol Cancer Ther; 2016 Aug; 15(8):1931-42. PubMed ID: 27196773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of metastasis, angiogenesis, and tumor growth by Chinese herbal cocktail Tien-Hsien Liquid.
    Chia JS; Du JL; Hsu WB; Sun A; Chiang CP; Wang WB
    BMC Cancer; 2010 Apr; 10():175. PubMed ID: 20429953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evodiamine exerts anti-tumor effects against hepatocellular carcinoma through inhibiting β-catenin-mediated angiogenesis.
    Shi L; Yang F; Luo F; Liu Y; Zhang F; Zou M; Liu Q
    Tumour Biol; 2016 Sep; 37(9):12791-12803. PubMed ID: 27449032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. tRNA synthetase counteracts c-Myc to develop functional vasculature.
    Shi Y; Xu X; Zhang Q; Fu G; Mo Z; Wang GS; Kishi S; Yang XL
    Elife; 2014 Jun; 3():e02349. PubMed ID: 24940000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular hierarchy of heparin-binding EGF-like growth factor-regulated angiogenesis in triple-negative breast cancer.
    Yotsumoto F; Tokunaga E; Oki E; Maehara Y; Yamada H; Nakajima K; Nam SO; Miyata K; Koyanagi M; Doi K; Shirasawa S; Kuroki M; Miyamoto S
    Mol Cancer Res; 2013 May; 11(5):506-17. PubMed ID: 23443317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The targetable nanoparticle BAF312@cRGD-CaP-NP represses tumor growth and angiogenesis by downregulating the S1PR1/P-STAT3/VEGFA axis in triple-negative breast cancer.
    Gong K; Jiao J; Xu C; Dong Y; Li D; He D; Zhao D; Yu J; Sun Y; Zhang W; Bai M; Duan Y
    J Nanobiotechnology; 2021 May; 19(1):165. PubMed ID: 34059068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMGA1 promotes breast cancer angiogenesis supporting the stability, nuclear localization and transcriptional activity of FOXM1.
    Zanin R; Pegoraro S; Ros G; Ciani Y; Piazza S; Bossi F; Bulla R; Zennaro C; Tonon F; Lazarevic D; Stupka E; Sgarra R; Manfioletti G
    J Exp Clin Cancer Res; 2019 Jul; 38(1):313. PubMed ID: 31311575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CTEN Inhibits Tumor Angiogenesis and Growth by Targeting VEGFA Through Down-Regulation of β-Catenin in Breast Cancer.
    Lu X; Zhou B; Cao M; Shao Q; Pan Y; Zhao T
    Technol Cancer Res Treat; 2021; 20():15330338211045506. PubMed ID: 34817293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-130b/TNF-α/NF-κB/VEGFA loop inhibits prostate cancer angiogenesis.
    Mu HQ; He YH; Wang SB; Yang S; Wang YJ; Nan CJ; Bao YF; Xie QP; Chen YH
    Clin Transl Oncol; 2020 Jan; 22(1):111-121. PubMed ID: 31667686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NCOA1 promotes angiogenesis in breast tumors by simultaneously enhancing both HIF1α- and AP-1-mediated VEGFa transcription.
    Qin L; Xu Y; Xu Y; Ma G; Liao L; Wu Y; Li Y; Wang X; Wang X; Jiang J; Wang J; Xu J
    Oncotarget; 2015 Sep; 6(27):23890-904. PubMed ID: 26287601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional regulation of VEGFA expression in T-regulatory cells from breast cancer patients.
    Kajal K; Bose S; Panda AK; Chakraborty D; Chakraborty S; Pati S; Sarkar T; Dhar S; Roy D; Saha S; Sa G
    Cancer Immunol Immunother; 2021 Jul; 70(7):1877-1891. PubMed ID: 33394094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa/VEGFR2/ERK pathway.
    Zhang Q; Lu S; Li T; Yu L; Zhang Y; Zeng H; Qian X; Bi J; Lin Y
    J Exp Clin Cancer Res; 2019 Apr; 38(1):173. PubMed ID: 31023337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eriocalyxin B, a natural diterpenoid, inhibited VEGF-induced angiogenesis and diminished angiogenesis-dependent breast tumor growth by suppressing VEGFR-2 signaling.
    Zhou X; Yue GG; Liu M; Zuo Z; Lee JK; Li M; Tsui SK; Fung KP; Sun H; Pu J; Lau CB
    Oncotarget; 2016 Dec; 7(50):82820-82835. PubMed ID: 27756875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.